UOC
GILD icon

UBS O'Connor’s Gilead Sciences GILD Stock Holding History

UBS O'Connor’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$686K – 545
2024
Q2 		$686K Buy
+10,000
New +$667K 0.02% 344
2022
Q4 		– Sell
-53,000
Closed -$3.27M – 782
2022
Q3 		$3.27M Buy
+53,000
New +$3.34M 0.04% 424
2013
Q3 		– Sell
-148,000
Closed -$7.58M – 482
2013
Q2 		$7.58M Buy
+148,000
New +$7.71M 0.14% 194

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

UBS O'Connor's GILD Position: Q3 2024 in Review

UBS O'Connor sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 10,000 shares — an estimated $686K sold.

UBS O'Connor first reported a position in GILD in Q2 2013 and held it in 3 quarters. The position peaked at $7.58M in Q2 2013. 1,721 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • UBS O'Connor reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • UBS O'Connor sold 10,000 Gilead Sciences shares in Q3 2024, an estimated $686K.
  • UBS O'Connor first reported a position in Gilead Sciences in Q2 2013 and held it in 3 quarters.
  • UBS O'Connor's Gilead Sciences position peaked at $7.58M in Q2 2013.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.